The Pan-African Veterinary Vaccines Center (AU-PANVAC), established by the African Union in Ethiopia in 2004, plays a pivotal role in ensuring the quality of veterinary vaccines utilized across Africa. As part of its mission, AU-PANVAC certifies a variety of vaccines employed in prophylactic programs on the continent, thereby safeguarding animal health and supporting agricultural development efforts. Furthermore, AU-PANVAC holds the esteemed designation of being a global reference laboratory for vaccine quality control, as recognized by both the World Organization for Animal Health (WOAH) and the Food and Agriculture Organization of the United Nations (FAO).
BIOPHARMA’s commitment to excellence in veterinary vaccines is underscored by its attainment of certification for its biological products from AU-PANVAC, a prestigious recognition sought after by veterinary services across various African states. This certification serves as a testament to the quality and adherence to international standards inherent in BIOPHARMA’s vaccines.
Through the dedication and expertise of its teams, BIOPHARMA consistently upholds the stringent requirements and protocols set forth by AU-PANVAC, ensuring that each batch of vaccines maintains the highest standards of quality and efficacy.
BIOPHARMA’s ongoing efforts to maintain this certification demonstrate its unwavering commitment to delivering safe, effective, and reliable vaccines to address the diverse needs of veterinary services and livestock producers throughout Africa.
By subjecting all production batches to rigorous quality control assessments by AU-PANVAC, BIOPHARMA reaffirms its dedication to transparency, accountability, and continuous improvement in veterinary vaccine manufacturing. This steadfast commitment to quality assurance not only enhances BIOPHARMA’s reputation as a trusted provider of veterinary vaccines but also contributes to the broader goals of promoting animal health, food security, and sustainable development across the African continent.